rs387906818
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_005257.6(GATA6):c.1366C>T(p.Arg456Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R456H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_005257.6 missense
Scores
Clinical Significance
Conservation
Publications
- atrial septal defect 9Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: G2P, Ambry Genetics
 - atrioventricular septal defect 5Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
 - GATA6-related congenital heart disease with or without pancreatic agenesis or neonatal diabetesInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
 - pancreatic hypoplasia-diabetes-congenital heart disease syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
 - metabolic syndromeInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
 - neonatal diabetes mellitusInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
 - tetralogy of fallotInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
 - familial atrial fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - conotruncal heart malformationsInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
 
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| GATA6 | ENST00000269216.10  | c.1366C>T | p.Arg456Cys | missense_variant | Exon 4 of 7 | 1 | NM_005257.6 | ENSP00000269216.3 | ||
| GATA6 | ENST00000581694.1  | c.1366C>T | p.Arg456Cys | missense_variant | Exon 3 of 6 | 1 | ENSP00000462313.1 | 
Frequencies
GnomAD3 genomes  Cov.: 32 
GnomAD2 exomes  AF:  0.00  AC: 0AN: 251490 AF XY:  0.00   
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF:  0.00  AC: 0AN: 1461838Hom.:  0  Cov.: 31 AF XY:  0.00  AC XY: 0AN XY: 727220 
GnomAD4 genome  Cov.: 32 
ClinVar
Submissions by phenotype
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome    Pathogenic:3Other:1 
This variant meets our criteria to be classified as pathogenic based upon segregation studies, absence from controls, and in-silico evaluation of pathogenicity. -
- -
Variant interpretted as Pathogenic and reported on 12-13-2017 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
- -
Congenital diaphragmatic hernia;C4049796:Abnormal cardiovascular system morphology    Pathogenic:1 
- -
Inborn genetic diseases    Pathogenic:1 
The c.1366C>T (p.R456C) alteration is located in exon 4 (coding exon 3) of the GATA6 gene. This alteration results from a C to T substitution at nucleotide position 1366, causing the arginine (R) at amino acid position 456 to be replaced by a cysteine (C). The GATA6 c.1366C>T alteration was flagged as a low confidence call in the Genome Aggregation Database (gnomAD). This variant has been determined to be the result of a de novo mutation in multiple individuals with features consistent with GATA6-related pancreatic agenesis and congenital heart defects (Allen, 2011; Yu, 2014). This amino acid position is highly conserved in available vertebrate species. This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. -
not provided    Pathogenic:1 
Published functional studies demonstrate a damaging effect by a loss of function for the transcription factor (Lango Allen H, 2012, 22158542); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 34850017, 34905512, 28938416, 32207556, 28303347, 32531870, 24385578, 22158542) -
Atrioventricular septal defect 5    Pathogenic:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at